Published 1 August 2005. doi:10.1084/jem.20051060
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 3, 445-455
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis
Niklas Beyersdorf1,
Stefanie Gaupp2,
Karen Balbach1,
Jens Schmidt2,
Klaus V. Toyka2,
Chia-Huey Lin1,
Thomas Hanke3,
Thomas Hünig1,
Thomas Kerkau1, and
Ralf Gold2,4
1 Institute for Virology and Immunobiology, University of Würzburg
2 Department of Neurology, University Hospital Würzburg, D-97078 Würzburg, Germany
3 TeGenero ImmunoTherapeutics AG, D-97076 Würzburg, Germany
4 Institute for MS Research, University of Göttingen and Gemeinnützige Hertie Stiftung, D-37073 Göttingen, Germany
CORRESPONDENCE Thomas Kerkau: kerkau{at}mail.uni-wuerzburg.de
CD4+CD25+ regulatory T cells (T reg cells) play a key role in controlling autoimmunity and inflammation. Therefore, therapeutic agents that are capable of elevating numbers or increasing effector functions of this T cell subset are highly desirable. In a previous report we showed that a superagonistic monoclonal antibody specific for rat CD28 (JJ316) expands and activates T reg cells in vivo and upon short-term in vitro culture. Here we demonstrate that application of very low dosages of the CD28 superagonist into normal Lewis rats is sufficient to induce T reg cell expansion in vivo without the generalized lymphocytosis observed with high dosages of JJ316. Single i.v. administration of a low dose of the CD28 superagonist into Dark Agouti (DA) rats or Lewis rats that suffered from experimental autoimmune encephalomyelitis (EAE) proved to be highly and equally efficacious as high-dose treatment. Finally, we show that T reg cells that were isolated from CD28-treated animals displayed enhanced suppressive activity toward myelin basic proteinspecific T cells in vitro, and, upon adoptive transfer, protected recipients from EAE. Our data indicate that this class of CD28-specific monoclonal antibodies targets CD4+CD25+ T reg cells and provides a novel means for the effective treatment of multiple sclerosis and other autoimmune diseases.
Abbreviations used: AT, adoptive transfer EAE; CFSE, carboxyfluorescein diacetate succinimidyl ester; CNS, central nervous system; CTLA-4, CTL-associated antigen 4; DA, Dark Agouti; EAE, experimental autoimmune encephalomyelitis; gpMBP, guinea pig MBP; LNC, lymph node cell; MBP, myelin basic protein; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; T reg cell, regulatory T cell; Tconv cell, conventional T cell.
N. Beyersdorf, S. Gaupp, T. Kerkau, and R. Gold contributed equally to this work.
S. Gaupp's present address is Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Isaacs, J. D.
(2008). Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future. Rheumatology (Oxford)
47: 1461-1468
[Abstract]
[Full Text]
-
Wang, J., Takeuchi, H., Sonobe, Y., Jin, S., Mizuno, T., Miyakawa, S., Fujiwara, M., Nakamura, Y., Kato, T., Muramatsu, H., Muramatsu, T., Suzumura, A.
(2008). Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc. Natl. Acad. Sci. USA
105: 3915-3920
[Abstract]
[Full Text]
-
Nolte-'t Hoen, E. N. M., Boot, E. P. J., Wagenaar-Hilbers, J. P. A., van Bilsen, J. H. M., Arkesteijn, G. J. A., Storm, G., Everse, L. A., van Eden, W., Wauben, M. H. M.
(2008). Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134. J. Leukoc. Biol.
83: 112-121
[Abstract]
[Full Text]
-
Hombach, A. A., Kofler, D., Hombach, A., Rappl, G., Abken, H.
(2007). Effective Proliferation of Human Regulatory T Cells Requires a Strong Costimulatory CD28 Signal That Cannot Be Substituted by IL-2. J. Immunol.
179: 7924-7931
[Abstract]
[Full Text]
-
Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., Mosley, R. L.
(2007). Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease. J. Leukoc. Biol.
82: 1083-1094
[Abstract]
[Full Text]
-
Chung, D. T., Korn, T., Richard, J., Ruzek, M., Kohm, A. P., Miller, S., Nahill, S., Oukka, M.
(2007). Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells. Int Immunol
0: dxm078v1-
[Abstract]
[Full Text]
-
Keino, H, Takeuchi, M, Usui, Y, Hattori, T, Yamakawa, N, Kezuka, T, Sakai, J-I, Usui, M
(2007). Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br. J. Ophthalmol.
91: 105-110
[Abstract]
[Full Text]
-
Tischner, D., Weishaupt, A., Brandt, J. v. d., Muller, N., Beyersdorf, N., Ip, C. W., Toyka, K. V., Hunig, T., Gold, R., Kerkau, T., Reichardt, H. M.
(2006). Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain
129: 2635-2647
[Abstract]
[Full Text]
-
Sharpe, A. H., Abbas, A. K.
(2006). T-Cell Costimulation -- Biology, Therapeutic Potential, and Challenges. NEJM
355: 973-975
[Full Text]
-
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., Panoskaltsis, N.
(2006). Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412. NEJM
355: 1018-1028
[Abstract]
[Full Text]
-
Gold, R., Linington, C., Lassmann, H.
(2006). Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain
129: 1953-1971
[Abstract]
[Full Text]
-
Legrand, N., Cupedo, T., van Lent, A. U., Ebeli, M. J., Weijer, K., Hanke, T., Spits, H.
(2006). Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2-/-{gamma}c-/- mice. Blood
108: 238-245
[Abstract]
[Full Text]